Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | VRTX | REGN | ||
| Company | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 49.14 | 397.30 | 904.54 | ||
| High | 49.14 | 406.34 | 908.67 | ||
| Low | 49.14 | 396.00 | 897.45 | ||
| Last | 49.15 | 405.10 | 906.51 | ||
| Change | +0.01 | +5.18 | +6.35 | ||
| % Change | +0.02% | +1.30% | +0.71% | ||
| Volume | 2,553 | 1,393,800 | 351,300 | ||
| 20-Day Average Volume | 10,496,317 | 960,430 | 441,525 | ||
| Previous Close | 49.14 | 394.28 | 896.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 50.56 | 404.73 | 931.83 | ||
| 20-Day Raw Stochastic | 22.26% | 29.27% | 11.27% | ||
| 20-Day Relative Strength | 42.36% | 43.46% | 36.34% | ||
| Weighted Alpha | -25.43 | +15.75 | +12.76 | ||
| Today's Opinion | 88% Sell | 8% Buy | 24% Buy | ||
| Previous Opinion | 88% Sell | 8% Buy | 24% Buy | ||
| Last Month's Opinion | 24% Sell | 40% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.83% since 04/16/24 | +0.64% since 04/15/24 | +0.18% since 04/15/24 | ||
| Low | 47.62 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 | ||
| High | 49.56 on 04/22/24 | 406.34 on 04/22/24 | 920.73 on 04/19/24 | ||
| 1-Month | |||||
| %Chg | -5.37% since 03/22/24 | -3.79% since 03/22/24 | -6.94% since 03/22/24 | ||
| Low | 47.62 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 | ||
| High | 54.47 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -1.95% since 01/23/24 | -9.13% since 01/22/24 | -4.53% since 01/22/24 | ||
| Low | 47.58 on 02/06/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 | ||
| High | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | -12.25% since 10/23/23 | +10.52% since 10/20/23 | +11.34% since 10/20/23 | ||
| Low | 47.58 on 02/06/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 | ||
| High | 56.77 on 10/25/23 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 99,594,944 | 103,362,928 | 98,803,360 | ||
| Shares Outstanding, K | 2,026,759 | 258,459 | 109,762 | ||
| Annual Sales | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 | ||
| Annual Net Income | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 | ||
| Last Quarter Sales | 11,477,000,000 | 2,517,700,000 | 3,434,300,000 | ||
| Last Quarter Net Income | 1,762,000,000 | 968,800,000 | 1,159,600,000 | ||
| 60-Month Beta | 0.39 | 0.35 | 0.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/02/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | ||
| Latest Earnings Date | 04/25/24 | 05/06/24 | 05/02/24 | ||
| Most Recent Dividend | 0.600 on 04/04/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 04/04/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.52 | 29.34 | 23.86 | ||